Skip navigation
PR Newswire

New Collaboration with StafaCT Will Optimize Patient Pathways for Cellular Treatments

Terumo BCT will now be the exclusive distributor for Stafa Cellular Therapy, a U.S.-based software developer.LAKEWOOD, Colo., Feb. 24, 2018 /PRNewswire/ -- Terumo BCT announced today that it will be the exclusive distributor for Stafa Cellular Therapy (StafaCT), a U.S.-based software developer. StafaCT software supports healthcare facilities and cell labs as they manage each phase of the cellular...